Chemistry:PEA-NBOMe

From HandWiki

PEA-NBOMe, also known as N-(2-methoxybenzyl)phenethylamine, is a drug of the phenethylamine and N-benzylphenethylamine (NB; NBOMe) families related to phenethylamine (PEA).[1][2] It is the N-(2-methoxybenzyl) derivative of phenethylamine.[1][2] The drug is a parent compound of the NBOMe family of psychedelic drugs, such as 25I-NBOMe.[1][2][3] No data on the pharmacology or toxicity of PEA-NBOMe are available.[1][2] In any case, based on structure–activity relationships, PEA-NBOMe might produce stimulant and/or hallucinogenic effects.[1][2] The drug was encountered as a novel designer drug online in 2024.[1][2] It is not a controlled substance in Canada as of 2025.[4]

See also

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 "PEA-NBOMe" (in ru). https://aipsin.com/newsubstance/1645/. 
  2. 2.0 2.1 2.2 2.3 2.4 2.5 "Psychoactive products market observation. Trend analysis." (in Russian). Monitoring the Psychoactive Product Market.. Aipsin Web Electronic Publication. January 2025. doi:10.13140/RG.2.2.11663.91045. https://www.researchgate.net/doi/10.13140/RG.2.2.11663.91045. 
  3. "Analytical characterization of bioactive N-benzyl-substituted phenethylamines and 5-methoxytryptamines". Rapid Communications in Mass Spectrometry 29 (7): 573–584. April 2015. doi:10.1002/rcm.7134. PMID 26212274. Bibcode2015RCMS...29..573B. https://researchonline.ljmu.ac.uk/id/eprint/3409/5/RCM-14-0447.R1_SuppInfo%5B1%5D.pdf. "Substances based on the N-(2-methoxybenzyl)phenethylamine template ('NBOMe' derivatives) play an important role in medicinal research but some of these derivatives have also appeared as 'research chemicals' for recreational use which has attracted attention worldwide.". 
  4. "Controlled Drugs and Substances Act". https://laws-lois.justice.gc.ca/eng/acts/c-38.8/FullText.html.